Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- GSK and Others See Massachusetts Showdown Over Drug-Marketing Reform
- There are two ideas floating in the world of politics to curb the way drug companies give doctors gifts and often biased information. One of them is a good idea, and one of them is a bad idea. Drug companies -- such as GlaxoSmithKline -- have chosen...
- Blog posts 2008-08-08
- Oxymoron No More: The Potential of Nonprofit Drug Companies to Deliver on the Promise of Medicines for the Developing World
- Although some pharmaceutical company efforts to develop and distribute drugs in developing countries have been successful, many fall short of meeting needs in resource-poor nations. The paper discusses the concept of a nonprofit pharmaceutical company dedicated to developing and distributing drugs for diseases endemic in developing countries. Using the experience...
- White papers 2005-08-01
- Drug Companies' Health Education Campaigns No Longer Speak Spanish
- For the first time in at least three years, drug companies have spent zero dollars on Spanish-language television for their unbranded health education ads, Nielsen-Monitor Plus reports. The wholescale write-off of Hispanic TV draws attention to how little Spanish-language provision there is in drug marketing. Of the...
- Blog posts 2008-10-03
- Wyeth v. Levine's Unintended Consequences: Prescription Data-Mining Banned in Vermont
- A federal court in Vermont has upheld a law preventing drug companies from "data-mining" prescription information from pharmacies. The court cited the U.S. Supreme Court's Wyeth v. Levine anti-preemption ruling as one of its reasons in doing so, suggesting that the Wyeth decision will consequences far beyond personal injury class-actions....
- Blog posts 2009-04-27
- Novartis, Boehringer Start Using Twitter Accounts
- AstraZeneca, Novartis, Vertex Pharmaceuticals and Boehringer Ingelheim have started experimenting with Twitter with varying degrees of enthusiasm, reports Pharmaceutical Executive. Drug companies have so far looked at social media with a mixture of fear and loathing. They believe perhaps wrongly that giving consumers more opportunities to talk...
- Blog posts 2009-02-18
- Drug Makers Gave Lobbyists an Xmas Gift -- Millions More to Lobby Obama Administration
- A New Year will bring a new president, a new FDA chief, many new drug regulations, and, possibly, health insurance reform. Mindful of the ton of major drug brands that will go off-patent in 2009, drug companies have not rested in their lobbying efforts over generics and patent issues. They...
- Blog posts 2008-12-31
Additional Resources
- FDA Issues Final Guidance on Record Keeping Guidelines; Ross Systems Supports Bioterrorism Compliance; Proven Food and Beverage Expertise Strengthened with New Product Management Hire; Solutions Showcased at Worldwide Food Expo 2005
- ATLANTA & CHICAGO -- In September 2005, The Food and Drug Administration FDA issued its final guidance to the food and beverage industry for Section 306 of the Bioterrorism Act. Ross Systems, Inc. ("Ross"), a global provider of enterprise software solutions for manufacturers and a division of CDC Software, the...
- Research articles 2005-10-25
- Tripos' SYBYL 7.0 Discovery Software Suite Now Available; Molecular Modeling and Computational Chemistry Software for Drug Discovery
- ST. LOUIS -- Tripos, Inc. (Nasdaq:TRPS), a leading provider of drug discovery informatics products and chemistry research, today announced the release of SYBYLR 7.0, the latest version of its expert molecular modeling environment for drug discovery research. Tripos' longstanding customer-focused approach enables the company to offer the new software release...
- Research articles 2004-10-05
- Fast Track Systems Introduces Enterprise Clinical Software for Global Protocol Development; TrialSpace Designer Optimizes Protocol Development, Eliminates Operational Inefficiencies
- Business Editors/Health/Medical Writers Drug Information Association's 40th Annual Meeting WASHINGTON--BUSINESS WIRE--June 14, 2004 Fast Track Systems, a technology and clinical information company, today announced the general availability of TrialSpace DesignerTM at the Drug Information Association's 40th Annual Meeting in Washington, D.C. TrialSpace Designer is the first and...
- Research articles 2004-06-14
- Monday Morning Update 10/5/09
- From Cernerfan: "Re: Barts 18-week backlog in thousands." In England, Cerner Millennium is blamed for the jump from 1,700 to 23,000 patients whose referrals don't meet the 18-week target from referral to treatment at Barts and the London NHS trust. They've been live since April 2008, so the "things are...
- News items 2009-10-07
- << Previous
- page 1 of 1
- Next >>
Presented by American Express